Olanzapine-induced diabetes mellitus

Annals of Pharmacotherapy

Volumn 35, Issue 5, 2001, Pages 563-565

  Bonanno, D G ^a   Davydov, L ^a   Botts, S R ^a  

^a PFIZER INC   (United States)

Author keywords

Antipsychotic; Diabetes mellitus; Olanzapine

Indexed keywords

GLUCOSE; OLANZAPINE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE PREDISPOSITION; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PANCREAS INJURY; PANCREAS ISLET CELL; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; SCHIZOIDISM; WEIGHT GAIN;

EID: 0035013397     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10280     Document Type: Article

References (18)

1. Hyperglycemia associated with olanzapine
2. Hyperglycemia and olanzapine
3. Diabetic ketoacidosis with olanzapine treatment
4. Olanzapine-induced ketoacidosis with diabetes mellitus
5. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment
6. Novel antipsychotics and new onset diabetes
7. A method for estimating the probability of adverse drug reactions
8. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy
9. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
10. Effects of sodium valproate in 100 children with special reference to weight
11. Effects of sodium valproate with special reference to weight
12. Monotherapy with valproate in primary generalized epilepsies
13. Sodium valproate: Monotherapy and polytherapy
14. Weight gain during treatment with valproate
15. Unwanted effects of sodium valproate (Epilim) in the treatment of adult patients with epilepsy
16. Conversion of valproate monotherapy in nonretarded adult with primary generalized tonic-clonic seizures